1,494 Shares in Danaher Co. (NYSE:DHR) Bought by Root Financial Partners LLC

Root Financial Partners LLC acquired a new position in Danaher Co. (NYSE:DHR) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund acquired 1,494 shares of the conglomerate’s stock, valued at approximately $343,000.

Other large investors also recently modified their holdings of the company. Heck Capital Advisors LLC bought a new stake in Danaher during the fourth quarter valued at about $27,000. Decker Retirement Planning Inc. bought a new stake in Danaher during the fourth quarter valued at about $31,000. Golden State Wealth Management LLC bought a new stake in Danaher during the fourth quarter valued at about $31,000. Strategic Financial Concepts LLC bought a new stake in Danaher during the fourth quarter valued at about $31,000. Finally, Pineridge Advisors LLC grew its holdings in Danaher by 63.3% during the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock valued at $34,000 after purchasing an additional 57 shares during the period. Institutional investors own 79.05% of the company’s stock.

Danaher Trading Up 1.5 %

Shares of DHR stock opened at $206.66 on Friday. Danaher Co. has a 1 year low of $196.80 and a 1 year high of $281.70. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. The stock’s 50 day simple moving average is $230.00 and its two-hundred day simple moving average is $249.96. The company has a market cap of $149.26 billion, a PE ratio of 39.14, a price-to-earnings-growth ratio of 2.68 and a beta of 0.83.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter in the prior year, the firm earned $2.09 EPS. Research analysts predict that Danaher Co. will post 7.67 earnings per share for the current year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, January 31st. Stockholders of record on Friday, December 27th were issued a $0.27 dividend. The ex-dividend date of this dividend was Friday, December 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.52%. Danaher’s payout ratio is 20.45%.

Insider Transactions at Danaher

In other news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the sale, the senior vice president now directly owns 20,230 shares in the company, valued at approximately $4,534,149.90. This represents a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Company insiders own 11.10% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on DHR shares. TD Cowen boosted their price target on Danaher from $310.00 to $315.00 and gave the company a “buy” rating in a report on Wednesday, October 23rd. Robert W. Baird dropped their price objective on Danaher from $277.00 to $268.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Barclays dropped their price objective on Danaher from $275.00 to $240.00 and set an “equal weight” rating for the company in a research note on Thursday, January 30th. Stifel Nicolaus upped their price objective on Danaher from $250.00 to $265.00 and gave the stock a “hold” rating in a research note on Wednesday, October 23rd. Finally, Wells Fargo & Company dropped their price objective on Danaher from $280.00 to $240.00 and set an “equal weight” rating for the company in a research note on Thursday, January 30th. Seven equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $278.00.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.